-thalassemia mutations in Israel (Englisch)
- Neue Suche nach: Tamary, H.
- Neue Suche nach: Shalmon, L.
- Neue Suche nach: Kirschmann, C.
- Neue Suche nach: Zaizov, R.
- Neue Suche nach: National Institutes of Health
- Neue Suche nach: Institut national de la sante et de la recherche medicale
- Neue Suche nach: Tamary, H.
- Neue Suche nach: Shalmon, L.
- Neue Suche nach: Kirschmann, C.
- Neue Suche nach: Zaizov, R.
- Neue Suche nach: Beuzard, Y.
- Neue Suche nach: Lubin, B.
- Neue Suche nach: Rosa, J.
- Neue Suche nach: National Institutes of Health
- Neue Suche nach: Institut national de la sante et de la recherche medicale
In:
New trends in therapy for hemoglobinopathies and thalassaemias: Sickle cell disease and thalassaemias; new trends in therapy
234
;
99
;
1995
-
ISBN:
-
ISSN:
- Aufsatz (Konferenz) / Print
-
Titel:-thalassemia mutations in Israel
-
Beteiligte:Tamary, H. ( Autor:in ) / Shalmon, L. ( Autor:in ) / Kirschmann, C. ( Autor:in ) / Zaizov, R. ( Autor:in ) / Beuzard, Y. / Lubin, B. / Rosa, J. / National Institutes of Health / Institut national de la sante et de la recherche medicale
-
Kongress:International conference, New trends in therapy for hemoglobinopathies and thalassaemias: Sickle cell disease and thalassaemias; new trends in therapy ; 1994 ; Paris
-
Erschienen in:
-
Verlag:
- Neue Suche nach: John Libbey Eurotext
-
Erscheinungsort:Paris , Les Editions INSERM
-
Erscheinungsdatum:01.01.1995
-
Format / Umfang:99 pages
-
Anmerkungen:Text in English, selected summaries in French
-
ISBN:
-
ISSN:
-
Medientyp:Aufsatz (Konferenz)
-
Format:Print
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis Konferenzband
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 3
-
Molecular control of globin gene switchingStamatoyannopoulos, G. / Li, Q. / Clegg, C. / Peterson, K. R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 9
-
Cis-/trans-regulation of chicken /curly epsilon-globin gene switchingEngel, J. D. / Foley, K. P. / Fraser, P. / Grosveld, F. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 19
-
Transcriptional regulation of the globin gene cluster (summary)Grosveld, F. / Fraser, P. / Philipsen, S. / Ellis, J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 21
-
Functional analysis of human curly epsilon-globin gene silencerRaich, N. / Stamatoyannopoulos, G. / Romeo, P.-H. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 31
-
Transcriptional and post-transcriptional mechanisms of curly epsilon-globin gene silencing (summary)Noguchi, C. T. / Peters, B. / Kollia, P. / Fibach, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 33
-
Isolation of Nrf2, a NF-E2 like bZip transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the -globin LCRMoi, P. / Chan, K. / Asunis, I. / Marini, G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 35
-
The transactivator CP2 is an integral component of the stage selector protein complexJane, S. M. / Nienhuis, A. W. / Cunningham, J. M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 43
-
A ferritin-like protein binds to a highly conserved CAGTGC sequence in the -globin promoterBroyles, R. H. / Blair, F. C. / Kyker, K. D. / Kurien, B. T. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 53
-
Somatic cell hybrids from transgenic mice in the analysis of embryonic fetal and adult globin gene regulationStanworth, S. J. / Roberts, N. A. / Sharpe, J. A. / Sloane-Stanley, J. A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 65
-
Regulation of the human -globin gene clusterHiggs, D. R. / Craddock, C. F. / Sharpe, J. A. / Gourdon, G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 75
-
Targeted inactivation of the HS-40 element of the human -globin gene locus via homologous recombinationBernet, A. / Sabatier, S. / Ouazana, R. / Morle, F. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 85
-
Nonsense mutated -globin mRNA: pathways of nuclear metabolism and possible significance for the protection against ineffective erythropoiesis in heterozygous -thalassemiaKulozik, A. E. / Kugler, W. / Enssle, J. / Hentze, M. W. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 97
-
Molecular basis of -thalassemia in Belgian families: detection of a novel frameshift mutationDerclaye, I. / Heusterspreute, M. / Malchaire, Y. / Philippe, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 98
-
Variation in fetal haemoglobin (HbF) levels among children with sickle cell anaemia in the UK the predominant Benin haplo-typeOfori-Acquah, S. F. / Pandya, J. K. / Henderson, S. / Bellingham, A. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 99
-
-thalassemia mutations in IsraelTamary, H. / Shalmon, L. / Kirschmann, C. / Zaizov, R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 100
-
Role of a region upstream of human -globin gene on the regulation of globin genes expressionVitale, M. / Di Marzo, R. / Calzolari, R. / Acuto, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 101
-
Diameteric regulation of human gamma globin and GATA-1 genes by short chain fatty acidsCaron, C. M. / Voss, J. W. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 102
-
The mouse -globin HS40-like element does not have LCR activity in transgenic mice when linked to the human -globin geneBouhassira, E. E. / Kielman, M. F. / Suzuka, S. / Bernini, L. F. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 103
-
Rapid molecular identification of deletional hereditary persistence of fetal hemoglobin type 2 (HPFH-type2)Goncalves, M. S. / Figueiredo, M. S. / Fahel, S. / Nechtman, J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 104
-
Novel mutations of -thalassaemia located in the untranslated regions of the -globin geneAthanassiadou, A. / Papachadjopoulou, A. / Zoumbos, N. / Maniatis, G. M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 105
-
Detecting African-American -thalassemia mutations using a single, rapid reverse dot blot hybridizationSutcharitchan, P. / Saiki, R. / Kutlar, A. / McKie, V. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 106
-
Homozygous -thalassemia with carrier state phenotypeRosatelli, M. C. / Pischedda, A. / Meloni, A. / Saba, L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 107
-
Localisation of a major gene for heterocellular HPFH to a region of chromosome 6qCraig, J. E. / Rochette, J. / Fisher, C. / Weatherall, D. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 111
-
Prospects for stem cell gene therapy (summary)Valerio, D. / Hoogerbrugge, P. / Van Beusechem, V. / Einerhand, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 113
-
Safe and efficient retroviral-mediated gene transfer into human hematopoietic progenitors (summary)Bank, A. / Ward, M. / Richardson, C. / Podda, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 115
-
Critical issues in the genetic treatment of hemoglobinopathiesSadelain, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 125
-
Progress towards the gene therapy of human -globin gene disorders using retroviral vectors that transfer -globin gene and -locus control region derivativesLeboulch, P. / Takekoshi, K. J. / Pawliuk, R. / Humphries, R. K. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 135
-
Retroviral transfer of a human gamma-globin gene linked to the -globin locus control region (LCR) results in high level expression in mouse erythroleukemia cellsAtweh, G. F. / Ren, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 137
-
Recombinant adeno-associated virus (rAAV) mediated transduction and expression of a human gamma-globin gene in CD34^+ selected peripheral blood cells from a patient with sickle cell anemiaMiller, J. L. / Donahue, R. E. / Sellers, S. E. / Samulski, R. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 141
-
Gene therapy strategy for sickle cell disease: transduction of pluripotent stem cells by AAV vectors (summary)Luhovy, M. / McCune, S. / Dong, J. Y. / Townes, T. M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 143
-
Gene therapy approaches in thalassaemia using P1-derived artificial chromosomes (PACs) and antisense oligonucleotidesIoannou, P. / Georghiou, A. / Bashiardes, E. / Kleanthous, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 145
-
Sustained delivery of erythropoietin in mice by genetically-modified skin fibroblastsNaffakh, N. / Henri, A. / Villeval, J.-L. / Rouyer-Fessard, P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 151
-
Adenovirus vector for the erythropoietin gene transferBlumenfeld, N. / Descamps, V. / Villeval, J.-L. / Kremer, E. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 157
-
Reversal of aberrant splicing of thalassemic pre-mRNAs by antisense oligonucleotidesKole, R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 165
-
Hydroxyurea effects in sickle cell anemia and -thalassemia patients result from both transcriptional and cell selection mechanisms (summary)Rodgers, G. P. / Zeng, Y. T. / Schechter, A. N. / Huang, S. Z. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 167
-
Hydroxyurea: an alternative treatment for recurrent stroke in selected sickle cell disease patients?Steinberg, M. H. / Ware, R. E. / Kinney, T. R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 169
-
Clinical and hematological response of sickle cell children to treatment with hydroxyureaDe Montalembert, M. / Belloy, M. / Bernaudin, F. / Philippe, N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 171
-
Hydroxyurea treatment in severely affected sickle cell disease childrenBelloy, M. / Ducrocq, R. / De Montalembert, M. / Krishnamoorthy, R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 173
-
Hydroxyurea/erythropoietin combination therapy for sickle cell diseaseEl-Hazmi, M. A. F. / Harakati, M. / Mohareb, F. / Al-Momen, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 177
-
Lessons for prospective clinical trials in the treatment of sickle cell anemia from the multicenter study of hydroxyureaCharache, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 185
-
Clinical trials with hydroxyurea in GreeceLoukopoulos, D. / Voskaridou, E. / Stamoulakatou, A. / Papasotiriou, J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 193
-
Hydroxyurea therapy in thalassemia intermediaCohen, A. R. / Martin, M. B. / Schwartz, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 195
-
Clinical effects of hydroxyurea in thalassemia intermedia patients (summary)Bachir, D. / Drame, M. / Lee, K. / Portos, J.-L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 197
-
Combination of erythropoietin and hydroxyurea results in improved quality and quantity of RBC in 7 patients with thalassemia intermediaAker, M. / Dover, G. / Schrier, S. / Rachmilewitz, E. A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 201
-
Hydroxyurea increases Hb F levels and improves the effectiveness of erythropoiesis in -thalassemia/Hb E diseaseFucharoen, S. / Siritanaratkul, N. / Chaicharoen, S. / Poolsup, N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 203
-
Long-term treatment with recombinant human erythropoietin in patients with thalassemia: reduction in requirement for transfusion and chelation therapyOlivieri, N. F. / MacKinnon, J. / Collins, A. F. / Sher, G. D. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 207
-
Beneficial use of r-HuEPO in sickle cell disease and thalassemia intermedia: interim results (summary)Cozma, G. / Momen, A. K. / Hazmi, M. A. F. / Politis, C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 209
-
Oral sodium phenylbutyrate therapy in homozygous thalassemia: a clinical trialCollins, A. F. / Pearson, H. A. / Giardina, P. / McDonagh, K. T. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 215
-
A novel butyric acid derivative stimulates fetal hemoglobin expressionRephaeli, A. / Zimra, Y. / Nudelman, A. / Ben-Dror, I. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 217
-
The two-phase liquid culture of human erythroid progenitors: application for studying sickling of erythroblasts from patients with sickle cell anemia (SCA)Fibach, E. / Hasegawa, S. / Schechter, A. N. / Noguchi, C. T. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 219
-
HbF induction in presence of increased 2-methyl-3-hydroxybutyric acid associated with 2-methylacetoacetil-CoA deficiency (summary)Galanello, R. / Lilliu, F. / Contini, L. / Podda, R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 223
-
Effects of alpha-thalassemia and hemoglobin F level on the severity of sickle cell anemiaLima, J. C. S. / Fleury, M. K. / Falcao, D. N. C. / Lobo, C. L. C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 224
-
Effect of hydroxyurea (HU) in patients with -thalassemia intermediaMandala, E. / Sinakos, Z. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 225
-
Induction of fetal hemoglobin by butyrate analogues in erythroid liquid culture from human peripheral blood stem cellsCappellini, M. D. / Stefanoni, I. / Tomaselli, C. / Bianchi, P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 226
-
Increased O~2 affinity conferred by hydroxyurea induced HbF in sickle cell disease is not adequate to prevent HbS polymerizationStamoulakatou, A. / Papassotiriou, I. / Perissaki, G. / Stamou, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 227
-
Erythropoietin induced increase of hemoglobin F in thalassemia intermedia does not contribute significantly to tissue oxygenationPapassotiriou, I. / Stamoulakatou, A. / Premetis, E. / Papalabrou, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 228
-
Administration of rHuEpo in sickle cell--thalassemia double heterozygotes during pregnancy and orthopedic surgeryBourantas, K. / Georgiou, J. / Malizos, K. / Tsiara, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 229
-
Long term efficacy of recombinant human erythropoietin in the treatment of patients with -haemoglobinopathiesPolitis, C. / Fragatou, S. / Hatzilaos, I. / Tzioka, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 230
-
Intravenous arginine butyrate therapy in patients with betahaemoglobinopathies: results of the Canadian trialSher, G. D. / Ginder, G. / Chang, L. / Dover, G. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 231
-
Recombinant human erythropoietin induced rapid and complete healing of chronic leg ulcers in two patients with thalassaemia intermediaPolitis, C. / Fragatou, S. / Messimeris, T. / Vrettou, H. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 232
-
Efficacy of hydroxyurea in treatment of Egyptian patients with -thalassaemia: preliminary results of a pilot clinical studyHassan, H. T. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 233
-
In vitro studies and HPLC determinations demonstrate that hydroxyurea may also induce denaturation of normal and sickle cell hemoglobinRoa, D. / Turner, E. A. / Roa, A. C. / Kopsombut, P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 234
-
Possible pharmacological manipulation of calcium ion from intracellular stores and stimulation of HbF synthesis in sickle cell disease by NX06999Fadulu, S. O. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 235
-
Hydroxyurea and phenylacetate decrease the number of BFU-E colonies in vitro in erythroid progenitors derived from sickle cell patientsYang, Y. M. / Baliga, B. S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 236
-
On a case of thalassemia intermedia and isoimmune hemolytic anaemia treated with rHuEpoTannoia, N. / Pietrapertosa, A. / Vitucci, A. / Ranieri, P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 237
-
Asociation of a 5' HS2-(AT)~XN~1~2(AT)~Y polymorphisms with levels of HbF and HbF/F cellPerichon, B. / Meier-Redelsperger, M. / Ducrocq, R. / Schilliroe, G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 241
-
Expression of normal and HPFH human globin genes in transgenic miceRomana, M. / Starck, J. / Scarpa, A. L. / Sarkar, R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 251
-
Deletion of mouse -globin and mouse -globin genes in embryonic stem cells (summary)Ciavatta, D. / Ryan, T. / Farmer, S. / McCune, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 253
-
Strategies for amelioration of sickle cell disease: use of the transgenic mouse for validation of antisickling strategiesFabry, M. E. / Suzuka, S. M. / Rubin, E. M. / Costantini, F. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 263
-
The SAD phenotype: sickle cell disease reproduced in transgenic miceDe Paepe, M. E. / Sorette, M. / Chretien, N. / Saadane, N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 271
-
rHuEPO, hydroxyurea and combined treatments in mouse -thalassemia: a model for treatment of human -thalassemiaDe Franceschi, L. / Rouyer-Fessard, P. / Brugnara, C. / Beuzard, Y. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 275
-
Decontamination of red cell componentsCorash, L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 285
-
Preoperative transfusion (TX) in sickle cell anemia (SCA)Vichinsky, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 287
-
Total blood transfusion in Zairian children and young adults suffering from sickle cell diseaseTshilolo, M. L. / Mukendi, K. R. / Wembonyama, O. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 289
-
Transfusion and infections in thalassaemia major (summary)Eleftheriou, A. / Angastiniotis, M. / Ioannou, P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 291
-
Oxygen transport by cell-free oxygen carriersWinslow, R. M. / Intaglietta, M. / Vandegriff, K. D. / Tsai, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 301
-
A phase I study of polymerized bovine hemoglobin (PBH) in adult patients with sickle cell disease not in crisis at the time of studyOrringer, E. P. / Gonzalez, P. M. / Hackney, A. C. / Jones, S. K. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 303
-
Strategies for blood substitutes: lessons from chemical modification and mutagenesis studies of hemoglobinManning, J. M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 305
-
Oxygen delivery using perfluorochemicals (summary)Riess, J. G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 307
-
Post-transfusion viral infection in patients with thalassaemiaDe Montalembert, M. / Lefrere, J.-J. / Girot, R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 309
-
-IFN in thalassemic patients with chronic hepatitis C virusFilosa, A. / Saviano, A. / Aponte, S. / Capasso, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 313
-
Structural and aggregation properties of a recombinant hemoglobin double mutant: sickle hemoglobin with Leu-88 () at the primary aggregation site substituted by AlaDe Llano, J. J. M. / Benjamin, L. J. / Manning, J. M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 314
-
The frequency of blood borne viruses (HBV, HCV and HIV) among Egyptian thalassemic childrenEl-Beshlawy, A. / Kaddah, N. / El-Hassan, A. A. / Eshak, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 315
-
Ten years clinical and hematological follow-up of HIV infected patients with thalassemiaLadis, V. / Theodoridou, M. / Berdoussi, H. / Mandalenaki, K. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 316
-
Viral infections in -thalassaemia multitransfused patientsMeo, A. / Miceli, M. / Cilia, S. / Minutoli, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 317
-
Prevalence of HCV antibodies in thalassaemiaMeo, A. / Miceli, M. / Cilia, S. / Minutoli, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 318
-
Effectiveness of low-dose intradermal hepatitis B vaccination in thalassemic patients: five years follow-upLeonardi, S. / Barone, P. / Sciacca, A. / Di Gregorio, F. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 319
-
Deferoxamine and interferon in thalassemic patients with chronic C hepatitis: does exist a therapeutic synergism?Leonardi, S. / Musumeci, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 320
-
Periodical model of hematopoiesis in thalassemic peopleFilosa, A. / Giani, U. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 321
-
Hepatitis C in patients with thalassemia and sickle cell syndromThuret, I. / Badens, C. / Michel, G. / Chambost, H. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 322
-
Thalassemia or thalassemic: towards a personalization of the transfusional regimen. A preliminary studyFilosa, A. / Esposito, G. / Galati, M. G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 323
-
Hepatitis markers in Brazilian patients with sickle cell diseasesArruda, V. R. / Eid, K. A. B. / Zen, G. C. / Goncalves, N. S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 324
-
The effect of chronic transfusion on sickle cell related illnessesStyles, L. / Vichinsky, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 325
-
Transfusion inefficiency and unexplained anaemia in sickle cell anaemiaSegbena, A. / Sanogo, I. / Ambofo, Y. / Sangare, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 326
-
Blood transfusions aspects in sickle cell anaemia patients in pediatrics at the Lome-Tokoin teaching hospitalSegbena, A. / Vovor, A. / Eko-Mba, J. M. / Tatagan, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 329
-
Studies of the orally active iron chelating agent deferiprone (L1) in thalassemiaOlivieri, N. F. / Brittenham, G. M. / Matsui, D. / Berkovitch, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 337
-
Clinical studies with the oral iron chelator deferiprone (L1)Al-Refaie, F. N. / Wonke, B. / Hoffbrand, A. V. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 349
-
Therapeutic potential of iron chelating treatment: modification of disease by iron depletionHershko, C. / Link, G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 359
-
Effect of iron loading on the metabolism and urinary recovery of 3-hydroxypyridin-4-one chelating agents in the ratChoudhury, R. / Singh, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 361
-
A fast, sensitive method to evaluate the potential of Fe-chelators to mobilize zinc (summary)Faller, B. / Nick, H. P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 363
-
Factors affecting the efficacy and toxicity of deferiprone (L1) in transfusional iron loaded patientsKontoghiorghes, G. J. / Sheppard, L. / Bartlett, L. / Bruckdorfer, K. R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 367
-
Design and development of orally active chelating agents: selective targeting of chelatable iron poolsSingh, S. / Choudhury, R. / Hider, R. C. / Porter, J. B. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 369
-
Further evaluation of HBED as an oral iron chelatorGrady, R. W. / Salbe, A. D. / Hilgartner, M. W. / Giardina, P. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 371
-
Thymocyte apoptosis: a rapid model for comparative screening of iron chelators. Implications for treatment of iron overload in thalassaemiaPorter, J. B. / Lynagh, G. R. / Hider, R. C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 373
-
Long-term intravenous deferoxamine treatment for non-compliant transfusion-dependent beta-thalassemia patientsTamary, H. / Goshen, J. / Carmi, D. / Yaniv, I. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 375
-
Treatment of iron stores in thalassemic patients with a regimen of continuous intravenous deferoxamine by a new disposable deviceLombardo, T. / Frontini, V. / Tamburino, C. / Bartoloni, G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 377
-
The effect of low dose desferrioxamine on ototoxicity in hemoglobinopathy patientsStyles, L. / Vichinsky, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 381
-
Update of iron chelation therapy with oral L~1 (deferiprone) worldwideKontoghiorghes, G. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 382
-
Recommendations for the use and monitoring of the oral chelating drug L1 or deferiprone by the I.C.O.C. committeeAgarwal, M. B. / Kontoghiorghes, G. J. / Tondury, P. / Kersten, M. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 383
-
A novel high molecular weight iron chelator produces prolonged, high plasma chelator levels in humansHedlund, B. E. / Hallaway, P. E. / Hanson, G. J. / Kling, P. J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 387
-
The ethics of prenatal diagnosis in different religious and cultural contextsWasi, P. / Fucharoen, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 389
-
Design and execution of clinical trials for the treatment of sickle cell anemiaCharache, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 395
-
From Hippocrates to hypothesis and beyond: how ethical is our research?Smith, J. A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 405
-
Ethics of bone marrow transplantation for sickle cell diseaseBernard, J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 411
-
Ethical problems in bone marrow transplantation for hemoglobinopathiesPiomelli, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 419
-
Ethical issues and fetal stem cell transplantation for -thalassemia-1Hayward, A. R. / Battaglia, F. / Hobbins, J. / Hsia, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 423
-
The cost of sickle cell disease in a developing country: an assessment of the economic cost in the Commonwealth of DominicaCallender, D. P. E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 427
-
Recent research developments in sickle cell disease in JamaicaSerjeant, G. R. / Serjeant, B. E. / Homi, J. / Knight, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 431
-
Ketorolac versus meperidine in vasooclusive crisis: a study of safety and efficacyGrisham, J. E. / Vichinsky, E. P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 433
-
Frequently recurring pain in sickle cell disease: assessment, treatment and prevention strategies (summary)Benjamin, L. / Swinson, G. / Fulchon, C. / McKegney, F. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 435
-
Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemiaVichinsky, E. / Williams, R. / Das, M. / Earles, A. N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 443
-
Death in sickle cell disease. The unexpected and the unexplainedDavies, S. C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 445
-
Can transfusion therapy prevent the first stroke in children with sickle cell anemia who are found by transcranial Doppler to have high cerebral artery flow velocity?Pegelow, C. H. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 447
-
Experience of genetic counseling and prenatal diagnosis for sickle-cell anemia in Guadeloupe, French West Indies (summary)Berchel, C. / Keclard, L. / Saint-Martin, C. / Diara, J.-P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 449
-
Progress in the management of thalassemia major: a decade and a half of experienceGiardina, P. J. / Ehlers, K. W. / Grady, R. W. / New, M. I. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 451
-
Correction of primary and secondary amenorrhoea and induction of ovulation by pulsatile infusion of gonadotrophin releasing hormone (GnRH) in patients with beta thalassaemia majorChatterjee, R. / Wonke, B. / Porter, J. B. / Katz, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 457
-
Molecular pathology and diagnosis of -thalassemia intermediaCao, A. / Galanello, R. / Rosatelli, M. C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 467
-
Hypercoagulability in patients with thalassemia intermediaCappellini, M. D. / Coppola, R. / Bottasso, B. / Potenza, I. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 469
-
Adrenarche and osteoporosis in prepubertal thalassemic patientsFilosa, A. / Di Maio, S. / Aponte, S. / Vocca, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 473
-
Neonatal screening for haemoglobinopathies in an English health regionHenthorn, J. / Nikolic, D. / Matthews, J. / Davies, S. C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 474
-
A seven year community experience of prenatal diagnosis (PND) for the haemoglobinopathies. Factors affecting uptakeDugan, B. T. A. / Acheampong, C. / Graham, V. V. / Okuyiga, E. O. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 475
-
Everyday life with sickle cell disease (SCD). The lessons from health diariesShand, P. A. X. / Fuggle, P. / Davies, S. C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 476
-
Selection of neonates for haemoglobinopathy screening by midwives does not workHenthorn, J. S. / Nikolic, D. / Davies, S. C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 477
-
Implementation of new treatment modalities for sickle cell patients in GermanyDickerhoff, R. / Klingebiel, T. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 478
-
Is piracetam useful in the treatment of sickle cell disease?El-Hazmi, M. A. F. / Warsy, A. S. / Opawoye, A. D. / Abu Taleb, H. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 479
-
Echocardiographic evaluation in -thalassemia major (10 years follow-up)Meo, A. / Calabro, M. P. / Nicosia, S. / Cavalli, G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 480
-
Glucose tolerance in thalassaemia patientsMeo, A. / Miceli, M. / Zappia, M. / Bianchini, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 481
-
Epidemiology survey of thalassemia trait in North East SicilyLa Rosa, M. A. / Meo, A. / Cafiero, G. / Cilia, S. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 482
-
Current skeletal findings in beta-thalassemia, following comprehensive therapyOrzincolo, C. / Castaldi, G. / Bariani, L. / Scutellari, P. N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 483
-
May vitamin A influence growth in homozygous thalassemic patients?Piga, A. / Sacchetti, L. / Garofalo, F. / Bertola, U. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 484
-
Natural history of sickle cell disease in Southern Zaire displays clinical specificitiesTshilolo, L. M. / Elion, J. / Girot, R. / Labie, D. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 485
-
Monitoring of RBC and reticulocyte hydration status and sickling-induced fragmentation during treatment of sickle cell anemia with hydroxyureaBallas, S. K. / Sorette, M. / Greenbaum, A. / Cremins, J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 486
-
Erythropoietin treatment of anemic crises in sickle cell patientsCastro, O. / Osuji, I. / Perlin, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 487
-
Protein C deficiency and cerebrovascular accident in a thalassemia patientKoren, A. / Abu Hana, M. / Peleg, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 488
-
Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life. Parisian prospective study on sickle cell disease (PPSSCD)Maier-Redelsperger, M. / Noguchi, C. T. / De Montalembert, M. / Rodgers, G. P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 489
-
Impact of counselling on the management of sickle cell disorders in AfricaOtaigbe, A. / Akinyanju, O. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 490
-
Self-medication of painful sickle cell episodesAkinyanju, O. / Otaigbe, A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 491
-
Rapid healing of chronic leg ulcers in patients with thalassaemia during treatment with hydroxyureaDi Palma, A. / Olivieri, N. / Sprocati, M. / Tenan, R. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 492
-
Prevalence of complications in medically treated thalassemia major and relation to iron burdenBorgna-Pignatti, C. / Rugolotto, S. / Verlato, G. / De Stefano, P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 495
-
Molecular basis for sickle cell adhesion to endothelium: potential implications for therapeutic strategies (summary)Mohandas, N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 497
-
Platelet-activating factor enhances adhesion of sickle erythrocytes to vascular endothelium: the role of vascular integrin ~v~3 and von Willebrand factorKaul, D. K. / Tsai, H. M. / Nagel, R. L. / Chen, D. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 501
-
Increased serum levels of phospholipase A~2 and free fatty acid in sickle cell disease associated with acute chest syndrome (ACS)Kuypers, F. A. / Styles, L. / Schalkwijk, C. G. / Hassell, K. L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 505
-
VCAM-1 is involved in mediating hypoxia-induced adherence of sickle red blood cells to both macro- and micro-vascular endothelium (summary)Stuart, M. J. / Setty, Y. B. N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 507
-
Microcirculation patterns in sickle cell disease (SCD) and assessment of therapeutic effects (buflomedil, HU)Bachir, D. / Maurel, A. / Beuzard, Y. / Portos, J.-L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 511
-
Oxidative processes in the pathobiology of sickle cell disease: potential opportunities for therapeutic interventionHebbel, R. P. / Repka, T. / Shalev, O. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 517
-
Protection of the erythrocyte membrane calmodulin stimulated Ca^+^+-ATPase against iron induced inhibition by U83836E (a vitamin E analog)Zaidi, A. / Marden, M. C. / Poyart, C. / Leclerc, L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 519
-
Oxidative stress in -thalassemic red blood cells and potential use of antioxidantsGrinberg, L. N. / Rachmilewitz, E. A. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 525
-
Blockade of erythrocyte Ca^2^+-actived K^+ transport: a potential new therapeutic approach for sickle cell diseaseBrugnara, C. / Armsby, C. C. / Sakamoto, M. / Rifai, N. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 535
-
Dipyridamole inhibits deoxygenation-induced cation fluxes in sickle cellsJoiner, C. H. / Jiang, M. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 545
-
Magnesium therapy for sickle cell anemia: a new rationaleBookchin, R. M. / Tiffert, J. T. / Davies, S. C. / Vichinsky, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 547
-
Two pathways for dense cell formation in sickle cells exposed to repeated in vitro cycles of oxygenation-deoxygenationSchwartz, R. S. / Musto, S. / Suzuka, S. M. / Nagel, R. L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 549
-
Compensatory mutations can restore function in mutant hemoglobinsHo, C. / Kim, H. W. / Shen, T. J. / Sun, D. P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 551
-
Polymerization of recombinant hemoglobin ~2~26(A3) Glu >Val, 7(A4) Glu >AlaLesecq, S. / Baudin, V. / Kiger, L. / Jonval, V. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 553
-
Design, synthesis, oxygen affinity and X-ray crystallographic studies of a novel class of covalent cross-linkers of hemoglobin subunitsBoyiri, T. / Safo, M. K. / Danso-Danquah, R. E. / Orringer, E. P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 555
-
Antisickling by metabolic depletion of erythrocyte 2,3-DPGPoillon, W. N. / Kim, B. C. / Kark, J. A. / Hicks, C. U. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 557
-
A recombinant biphosphoglycerate mutase variant with acid phosphatase homology degrades 2,3-diphosphoglycerate: a possible new therapeutic approach of sickle cell diseaseGarel, M.-C. / Arous, N. / Calvin, M.-C. / Craescu, C. T. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 561
-
Membrane protein phosphorylation and sickle cell dehydrationFathallah, H. / Coezy, E. / De Neef, R. S. / Hardy-Dessources, M. D. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 562
-
Heme degradation in the presence of glutathione: a proposed mechanism for heme degradation in abnormal red blood cellsAtamna, H. / Ginsburg, H. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 565
-
Bone marrow transplantation in thalassemiaLucarelli, G. / Galimberti, M. / Angelucci, E. / Baronciani, D. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 571
-
Collaborative study of marrow transplantation for symptomatic sickle cell anemia (summary)Sullivan, K. M. / Walters, M. C. / Bernaudin, F. / Souillet, G. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 573
-
Allogeneic bone marrow transplantation in severe pediatric sickle cell disease: report of the French experience with 22 casesBernaudin, F. / Souillet, G. / Vannier, J.-P. / Vilmer, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 579
-
Patients with sickle cell anemia who present graft failure after bone marrow transplantation may develop increased levels of fetal hemoglobin associated with improved clinical presentationFerster, A. / Corazza, F. / Bujan, W. / Devalck, C. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 581
-
Origin of different hematologic lineages in stable mixed chimeras after BMT in thalassemiaAndreani, M. / Nesci, S. / Manna, M. / Tonucci, P. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 583
-
Use of cord blood for treament of patients with congenital hemoglobinopathiesGluckman, E. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 589
-
Functional studies of human long-term culture-initiating cells (LTC-IC) in vitro and in vivoEaves, C. / Zandstra, P. / Ponchio, L. / Cashman, J. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 595
-
Expansion of cord blood progenitor cells from unfractionated samples (summary)Gabutti, V. / Miniero, R. / Crescenzio, N. / Ruggieri, L. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995
- 597
-
In utero hematopoietic stem cell transplantationsZanjani, E. D. / Flake, A. W. / National Institutes of Health / Institut national de la sante et de la recherche medicale et al. | 1995